12/20
07:36 am
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $6.00 price target on the stock, down previously from $15.00.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $6.00 price target on the stock, down previously from $15.00.
12/20
07:36 am
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $6.00 price target on the stock, down previously from $15.00.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $6.00 price target on the stock, down previously from $15.00.
12/20
06:35 am
caba
Rating for CABA
Medium
Report
Rating for CABA
12/20
05:41 am
caba
Cabaletta Bio downgraded to In Line from Outperform at Evercore ISI
Medium
Report
Cabaletta Bio downgraded to In Line from Outperform at Evercore ISI
12/20
05:41 am
caba
Cabaletta Bio downgraded to In Line from Outperform at Evercore ISI
Medium
Report
Cabaletta Bio downgraded to In Line from Outperform at Evercore ISI
12/19
07:44 am
caba
Rating for CABA
Low
Report
Rating for CABA
12/19
07:44 am
caba
Rating for CABA
Low
Report
Rating for CABA
12/19
07:42 am
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $6.00 price target on the stock, down previously from $12.00.
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $6.00 price target on the stock, down previously from $12.00.
12/19
05:40 am
caba
Cabaletta Bio downgraded to Equal Weight from Overweight at Wells Fargo
Low
Report
Cabaletta Bio downgraded to Equal Weight from Overweight at Wells Fargo
12/19
05:40 am
caba
Cabaletta Bio downgraded to Equal Weight from Overweight at Wells Fargo
Low
Report
Cabaletta Bio downgraded to Equal Weight from Overweight at Wells Fargo
11/18
05:41 pm
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "outperform" rating re-affirmed by analysts at William Blair.
11/18
05:41 pm
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "outperform" rating re-affirmed by analysts at William Blair.
11/15
02:12 pm
caba
Rating for CABA
Low
Report
Rating for CABA
11/15
02:12 pm
caba
Rating for CABA
Low
Report
Rating for CABA
11/15
08:03 am
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
High
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
10/10
09:27 am
caba
Rating for CABA
Medium
Report
Rating for CABA
10/10
07:32 am
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $10.00 price target on the stock.